George K. Ng - Chief Executive Officer, Director at Processa Pharmaceuticals, Inc.

Issuer-level insider activity

Role: Chief Executive Officer, Director
Issuer ticker: PCSA on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

Past-year transaction volume for George K. Ng in Processa Pharmaceuticals, Inc.

Buys

Open market

Shares: +17,350
Avg price: $2.54
Total value: +$44,151

Sells

Open market

Shares
Avg price
Total value

Net

Past year

Shares: +17,350
Share %: 100%
Total value: +$44,151

Reported holdings for George K. Ng in Processa Pharmaceuticals, Inc.

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 17,092
Estimated value: $39,039
Report date: 08 Aug 2026
Price: $2.52
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 87,200
Estimated value: $18,312
Report date: 24 Jul 2025
Price: $0.2100
Ownership: George Ng IRRA FBO: George Ng

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Warrants
Shares / value: 43,600
Estimated value: $9,156
Report date: 24 Jul 2025
Price: $0.2100
Ownership: George Ng IRRA FBO: George Ng
Underlying class: Common Stock
Underlying amount: 43,600

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 3,488
Estimated value: $8,789
Report date: 08 Aug 2026
Price: $2.52
Ownership: George Ng IRRA FOB George Ng

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Common Stock
Shares / value: 800
Estimated value: $2,016
Report date: 08 Aug 2026
Price: $2.52
Ownership: Ng Cha Family Trust

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Stock Options (Right to Buy)
Shares / value: 30,720
Estimated value
Report date: 08 Aug 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Restricted Stock Units
Shares / value: 21,224
Estimated value
Report date: 26 Jul 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Chief Executive Officer, Director

Processa Pharmaceuticals, Inc.

Security class: Restricted Stock
Shares / value: 19,624
Estimated value
Report date: 08 Aug 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Transaction history for George K. Ng in Processa Pharmaceuticals, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .